Predictive Factors of Pulmonary Embolism in Older Patients with SARS-CoV-2: The OCTA-COVID-19 Study

被引:2
|
作者
Quezada-Feijoo, Maribel [1 ,2 ]
Ramos, Monica [1 ,2 ]
Lozano-Montoya, Isabel [2 ,3 ]
Toro, Rocio [4 ,5 ]
Jaramillo-Hidalgo, Javier [2 ,3 ]
Fernandez de la Puente, Eva [3 ]
Garmendia, Blanca [2 ,3 ]
Carrillo, Pamela [2 ,3 ]
Cristofori, Giovanna [3 ]
Goni Roson, Saleta [3 ]
Ayala, Rocio [1 ,2 ]
Sarro, Monica [6 ]
Gomez-Pavon, Francisco J. [2 ,3 ]
机构
[1] Hosp Cent Cruz Roja, Cardiol Dept, C Reina Victoria 24, Madrid 28003, Spain
[2] Alfonso X El Sabio Univ, Sch Med, Avda Univ 1, Madrid 28691, Spain
[3] Hosp Cent Cruz Roja, Geriatr Dept, C Reina Victoria 24, Madrid 28003, Spain
[4] Puerta Mar Univ Hosp, Res Unit, Biomed Res & Innovat Inst Cadiz INiBICA, Av Ana Viya 21, Cadiz 11009, Spain
[5] Cadiz Univ, Sch Med, Med Dept, Edificio Andres Segovia 3 Floor,C Dr Maranon S-N, Cadiz 21001, Spain
[6] Hosp Cent La Cruz Roja, Radiol Dept, C Reina Victoria 24, Madrid 28003, Spain
关键词
pulmonary embolism; older; COVID-19; VENOUS THROMBOEMBOLISM; COVID-19; PATIENTS; D-DIMER; EPIDEMIOLOGY; THROMBOSIS; FRAILTY;
D O I
10.3390/jcm10132998
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The risk of pulmonary embolism (PE) has not been studied in older patients affected by COVID-19. We aimed to assess PE incidence and risk factors in a population of older patients infected with SARS-CoV-2. Methods: An ambispective, observational cohort study. A total of 305 patients >= 75 years old had the SARS-CoV-2 infection from March to May 2020. The incidence rate of PE was estimated as the proportion of new cases within the whole sample. Youden's index was used to assess the cutoff point of D-dimer. To select factors associated with the risk of PE, time-to-event analyses were performed using cause-specific hazard models. Results: In total, 305 patients with a median age of 87 years (62.3% female) were studied; 67.9% were referred from nursing homes and 90.4% received any type of anticoagulation. A total of 64.9% showed frailty and 44% presented with dementia. The PE incidence was 5.6%. The cutoff value of a D-dimer level over 2.59 mg/L showed a sensitivity of 82.4% and specificity of 73.8% in discriminating a PE diagnosis. In the multivariate analysis, the factors associated with PE were previous oncological events and D-dimer levels. Conclusions: The PE incidence was 5.6%, and major risk factors for PE were oncological antecedents and increased plasma D-dimer levels.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] SARS-CoV-2 Infection: Modulator of Pulmonary Embolism Paradigm
    Akhter, Mohammad Suhail
    Hamali, Hassan A.
    Mobarki, Abdullah A.
    Rashid, Hina
    Oldenburg, Johannes
    Biswas, Arijit
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (05) : 1 - 20
  • [2] Prediction of pulmonary embolism in patients with SARS-CoV-2 infection
    Gil Mosquera, Manuel
    Fernandez-Ruiz, Mario
    Sanz Rodriguez, Elena
    Mata Martinez, Aranzazu
    Ibanez Sanz, Lain
    Munoz Martin, David
    Bisbal Pardo, Otilia
    Martinez Chamorro, Elena
    MEDICINA CLINICA, 2022, 158 (05): : 206 - 210
  • [3] Pulmonary embolism and SARS-CoV-2: analysis of the characteristics of patients admitted to a center in northern Italy for pulmonary embolism associated with COVID-19
    Zanchi, Simone
    La Greca, Carmelo
    Forgione, Chiara
    Bettari, Luca
    Cortinovis, Sarah
    Pero, Gaetano
    Pecora, Domenico
    Botti, Paolo
    Bna, Claudio
    Cuccia, Claudio
    GIORNALE ITALIANO DI CARDIOLOGIA, 2021, 22 (09) : 704 - 711
  • [4] SARS-CoV-2 antibody research in patients with unprovoked pulmonary embolism in COVID-19 pandemic period
    Atahan, Ersan
    Karabul, Emine
    Akcin, Ruveyda
    Ozturk, Buket Caliskaner
    Gencer, Aysegul
    Kocazeybek, Bekir
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (04) : 587 - 592
  • [5] Pulmonary embolism in pediatric and adolescent patients with COVID-19 infection during the SARS-CoV-2 delta wave
    Cohen, Clay T.
    Riedl, Ruth A.
    Gowda, Srinath T.
    Sartain, Sarah E.
    Bashir, Dalia A.
    PEDIATRIC BLOOD & CANCER, 2022, 69 (08)
  • [6] SARS-CoV-2 and pulmonary embolism: who stole the platelets?
    Michael Tran
    Chirag Sheth
    Rohan Bhandari
    Scott J. Cameron
    Deborah Hornacek
    Thrombosis Journal, 18
  • [7] SARS-CoV-2 and pulmonary embolism: who stole the platelets?
    Tran, Michael
    Sheth, Chirag
    Bhandari, Rohan
    Cameron, Scott J.
    Hornacek, Deborah
    THROMBOSIS JOURNAL, 2020, 18 (01)
  • [8] SARS-CoV-2 antibody research in patients with unprovoked pulmonary embolism in COVID-19 pandemic period
    Ersan Atahan
    Emine Karabul
    Ruveyda Akcin
    Buket Caliskaner Ozturk
    Aysegul Gencer
    Bekir Kocazeybek
    Journal of Thrombosis and Thrombolysis, 2022, 54 : 587 - 592
  • [9] Pulmonary embolism after SARS-CoV-2 vaccination
    Zethelius, Bjorn
    Attelind, Sofia
    Westman, Gabriel
    Ljung, Rickard
    Sundstrom, Anders
    VACCINE: X, 2024, 21
  • [10] Consider alternative causes of thrombo-embolism to SARS-CoV-2 in COVID-19 patients
    Finsterer, Josef
    Scorza, Fulvio A.
    ANNALS OF MEDICINE AND SURGERY, 2022, 78